DataMeds AI, Inc. Proceeds from Lines of Credit
DataMeds AI, Inc. (MEDS) reported Proceeds from Lines of Credit of $17.15 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-08-17
- DataMeds AI, Inc. proceeds from lines of credit for fiscal 2024 was $756.48K.
| Period end | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 12 month |
|---|---|---|
| 2025-06-30 | $17.15M 10-Q · filed 2026-08-17 | |
| 2024-12-31 | $756.48K 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |